07 June 2016
Any snapshot of the current state of the U.S. health care industry must heavily emphasize how the latest developments in new policies are affecting payments. As is evidenced by the plunge in completed mergers and acquisitions (M&A) activity in the first quarter, 2016 will continue to be more affected by either the advent of new policies affecting payment structures and more or continued uncertainty around potential political policy swings down the road, not to mention regulatory action to prevent monopolies in certain regions forming. The timing of policy changes, particularly those driven by political swings, should be taken into account by executives in the middle market, as it could be quite some time before significant changes begin to be implemented. But by and large, the health care industry as a whole is still grappling with the effects of evolving government policies. Such transformation will continue to drive the development and adoption of new, compensatory business strategies among both providers and payers.
Key highlights from the first quarter:
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Research calls for greater investment in Alzheimer’s clinical trials
03 May 2024
Stress impact on protein particle formation for monoclonal antibody formulation
03 May 2024
Health Ministry registered Russian drug for ankylosing spondylitis
02 May 2024
Production of finished drugs in Russia grew by 13.8%
02 May 2024